Impact of hepatectomy and postoperative adjuvant transarterial chemoembolization on serum tumor markers and prognosis in intermediate-stage hepatocellular carcinoma

doi:10.4240/wjgs.v15.i12.2820

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2581)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

WORD

HTML

1179

Figures (1-2)

252

Tables (1-4)

293

Sum=1802

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

127

Download

570

Sum=697

Dec 27, 2023 (publication date) through Feb 24, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Dec 27, 2023; 15(12): 2820-2830
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2820

Table 2 Clinical efficacy assessment

Clusters	CR	PR	SD	PD	Overall mitigation rate
Control group (n = 50)	9	26	9	6	35 (70.00%)
Observation group (n = 58)	20	30	3	5	50 (86.20%)
χ² value					4.208
P value					0.040^a

^aP < 0.05.

CR: Complete remission; PR: Partial remission; SD: Stable disease; PD: Progressive disease.

Citation: Hu YD, Zhang H, Tan W, Li ZK. Impact of hepatectomy and postoperative adjuvant transarterial chemoembolization on serum tumor markers and prognosis in intermediate-stage hepatocellular carcinoma. World J Gastrointest Surg 2023; 15(12): 2820-2830
URL: https://www.wjgnet.com/1948-9366/full/v15/i12/2820.htm
DOI: https://dx.doi.org/10.4240/wjgs.v15.i12.2820